Kininogen LC Antibodies

Santa Cruz Biotechnology offers a broad range of Kininogen LC monoclonal antibodies for investigating kininogen's role in various biological processes. Kininogen LC monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Kininogen is a key plasma protein that serves as a precursor to kinins, which are important mediators in inflammation, blood pressure regulation, and pain response. Research focused on Kininogen LC continues to reveal its critical role in the kinin-kallikrein system and its implications in various pathological conditions, including cardiovascular diseases and inflammatory disorders. Understanding Kininogen LC function can provide insights into therapeutic targets for managing these conditions. Researchers worldwide rely on Kininogen LC monoclonal antibodies to advance their studies in cardiovascular and inflammatory research. The molecular mechanisms of Kininogen LC remain an active area of investigation, with new findings emerging regularly about its involvement in disease progression and potential therapeutic applications. Ongoing research utilizing Kininogen LC monoclonal antibodies has highlighted significant pathways in blood pressure regulation and inflammatory responses. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to understanding disease mechanisms and developing new therapeutic strategies.